NM_005235.3:c.2867-105T>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005235.3(ERBB4):​c.2867-105T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.298 in 737,032 control chromosomes in the GnomAD database, including 36,581 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.25 ( 5359 hom., cov: 32)
Exomes 𝑓: 0.31 ( 31222 hom. )

Consequence

ERBB4
NM_005235.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.608

Publications

8 publications found
Variant links:
Genes affected
ERBB4 (HGNC:3432): (erb-b2 receptor tyrosine kinase 4) This gene is a member of the Tyr protein kinase family and the epidermal growth factor receptor subfamily. It encodes a single-pass type I membrane protein with multiple cysteine rich domains, a transmembrane domain, a tyrosine kinase domain, a phosphotidylinositol-3 kinase binding site and a PDZ domain binding motif. The protein binds to and is activated by neuregulins and other factors and induces a variety of cellular responses including mitogenesis and differentiation. Multiple proteolytic events allow for the release of a cytoplasmic fragment and an extracellular fragment. Mutations in this gene have been associated with cancer. Alternatively spliced variants which encode different protein isoforms have been described; however, not all variants have been fully characterized. [provided by RefSeq, Jul 2008]
ERBB4 Gene-Disease associations (from GenCC):
  • amyotrophic lateral sclerosis type 19
    Inheritance: AD Classification: STRONG, MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • amyotrophic lateral sclerosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 2-211422209-A-T is Benign according to our data. Variant chr2-211422209-A-T is described in ClinVar as Benign. ClinVar VariationId is 1278598.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.512 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ERBB4NM_005235.3 linkc.2867-105T>A intron_variant Intron 23 of 27 ENST00000342788.9 NP_005226.1 Q15303-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ERBB4ENST00000342788.9 linkc.2867-105T>A intron_variant Intron 23 of 27 1 NM_005235.3 ENSP00000342235.4 Q15303-1
ERBB4ENST00000436443.5 linkc.2867-105T>A intron_variant Intron 23 of 26 1 ENSP00000403204.1 Q15303-3
ERBB4ENST00000260943.11 linkc.2837-105T>A intron_variant Intron 23 of 26 5 ENSP00000260943.7 Q15303-4H3BLT0

Frequencies

GnomAD3 genomes
AF:
0.249
AC:
37834
AN:
151704
Hom.:
5350
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.130
Gnomad AMI
AF:
0.183
Gnomad AMR
AF:
0.286
Gnomad ASJ
AF:
0.243
Gnomad EAS
AF:
0.358
Gnomad SAS
AF:
0.528
Gnomad FIN
AF:
0.263
Gnomad MID
AF:
0.280
Gnomad NFE
AF:
0.285
Gnomad OTH
AF:
0.253
GnomAD4 exome
AF:
0.310
AC:
181548
AN:
585210
Hom.:
31222
AF XY:
0.324
AC XY:
102800
AN XY:
317524
show subpopulations
African (AFR)
AF:
0.122
AC:
1926
AN:
15734
American (AMR)
AF:
0.305
AC:
11036
AN:
36158
Ashkenazi Jewish (ASJ)
AF:
0.262
AC:
5011
AN:
19122
East Asian (EAS)
AF:
0.417
AC:
12879
AN:
30912
South Asian (SAS)
AF:
0.526
AC:
34166
AN:
64984
European-Finnish (FIN)
AF:
0.271
AC:
9946
AN:
36690
Middle Eastern (MID)
AF:
0.347
AC:
1350
AN:
3894
European-Non Finnish (NFE)
AF:
0.278
AC:
96589
AN:
347408
Other (OTH)
AF:
0.285
AC:
8645
AN:
30308
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
6464
12928
19393
25857
32321
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1072
2144
3216
4288
5360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.249
AC:
37861
AN:
151822
Hom.:
5359
Cov.:
32
AF XY:
0.255
AC XY:
18896
AN XY:
74204
show subpopulations
African (AFR)
AF:
0.129
AC:
5371
AN:
41518
American (AMR)
AF:
0.286
AC:
4359
AN:
15226
Ashkenazi Jewish (ASJ)
AF:
0.243
AC:
840
AN:
3462
East Asian (EAS)
AF:
0.358
AC:
1845
AN:
5148
South Asian (SAS)
AF:
0.529
AC:
2542
AN:
4804
European-Finnish (FIN)
AF:
0.263
AC:
2783
AN:
10576
Middle Eastern (MID)
AF:
0.288
AC:
84
AN:
292
European-Non Finnish (NFE)
AF:
0.285
AC:
19330
AN:
67772
Other (OTH)
AF:
0.256
AC:
540
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1420
2840
4260
5680
7100
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
412
824
1236
1648
2060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.257
Hom.:
623
Bravo
AF:
0.238
Asia WGS
AF:
0.436
AC:
1512
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
May 11, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Jul 31, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 28% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy, Progressive Myoclonus Epilepsy and Abnormal Movements and Neurodegeneration with brain iron accumulation. Number of patients: 26. Only high quality variants are reported. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
1.6
DANN
Benign
0.59
PhyloP100
-0.61
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3791709; hg19: chr2-212286934; API